Nanoparticle–aptamer bioconjugates for cancer targeting
- 26 April 2006
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Drug Delivery
- Vol. 3 (3) , 311-324
- https://doi.org/10.1517/17425247.3.3.311
Abstract
The combination of targeted drug delivery and controlled-release technology may pave the road for more effective yet safer chemotherapeutic options for cancer therapy. Drug-encapsulated polymeric n...Keywords
This publication has 98 references indexed in Scilit:
- Influence of polysaccharide coating on the interactions of nanoparticles with biological systemsBiomaterials, 2006
- Microfluidic System for Studying the Interaction of Nanoparticles and Microparticles with CellsAnalytical Chemistry, 2005
- Her-2/neu Overexpression and Amplification in Uterine Papillary Serous CarcinomaJournal of Clinical Oncology, 2004
- Treatment outcome of two-stage revision total hip arthroplasty for infected hip arthroplasty using antibiotic-impregnated cement spacerJournal of Orthopaedic Science, 2003
- Scaling down imaging: molecular mapping of cancer in miceNature Reviews Cancer, 2002
- New developments in the treatment of type 1 diabetes mellitusExperimental and Clinical Endocrinology & Diabetes, 1999
- Biodegradable Long-Circulating Polymeric NanospheresScience, 1994
- Increased bone marrow toxicity of doxorubicin bound to nanoparticlesEuropean Journal Of Cancer, 1994
- In vitro selection of RNA molecules that bind specific ligandsNature, 1990
- Systematic Evolution of Ligands by Exponential Enrichment: RNA Ligands to Bacteriophage T4 DNA PolymeraseScience, 1990